0001144204-18-063348.txt : 20181206 0001144204-18-063348.hdr.sgml : 20181206 20181206132308 ACCESSION NUMBER: 0001144204-18-063348 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181203 FILED AS OF DATE: 20181206 DATE AS OF CHANGE: 20181206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ren Ken Keyong CENTRAL INDEX KEY: 0001545181 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20713 FILM NUMBER: 181219992 MAIL ADDRESS: STREET 1: 9640 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CASI Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0000895051 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 581959440 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9620 MEDICAL CENTER DR STREET 2: STE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-864-2600 MAIL ADDRESS: STREET 1: 9620 MEDICAL CENTER DR STREET 2: STE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: ENTREMED INC DATE OF NAME CHANGE: 19960415 4 1 tv508522_4.xml OWNERSHIP DOCUMENT X0306 4 2018-12-03 0 0000895051 CASI Pharmaceuticals, Inc. CASI 0001545181 Ren Ken Keyong CASI PHARMACEUTICALS, INC. 9620 MEDICAL CENTER DRIVE, SUITE 300 ROCKVILLE MD 20850 1 1 0 0 Chief Executive Officer Stock Options (Right to Buy) 0.99 2018-12-03 4 A 0 720000 0 A 2018-12-03 2027-08-14 Common Stock 720000 720000 D On August 14, 2017, the reporting person was granted an option to purchase 720,000 shares of common stock that vest upon achievement of certain performance based conditions. The performance based condition was satisfied on December 3, 2018, resulting in vesting of the option. /s/ Cynthia W. Hu, attorney-in-fact for Ken K. Ren 2018-12-05